Characteristic or exposure | All patient-days with completed RCSQ (n = 1372) | Patient-completed RCSQ (n = 724) | Nurse-completed RCSQ (n = 648) | P valuea |
---|---|---|---|---|
Overall sleep quality, per 10 points on RCSQb | 58 (33–77) | 58 (33–78) | 57 (35–75) | 0.82 |
Baseline variables | Â | Â | Â | Â |
Age, median (IQR), y | 55 (45–66) | 57 (45–68) | 53 (44–65) | 0.02 |
Female sex, n (%) | 568 (41) | 297 (41) | 271 (42) | 0.89 |
Race, n (%) | Â | Â | Â | 0.87 |
 White | 694 (51) | 388 (54) | 306 (47) |  |
 Black | 517 (38) | 235 (32) | 282 (44) |  |
 Other | 161 (12) | 101 (14) | 60 (9) |  |
Ambulatory status prior to ICU admission, n (%) | Â | Â | Â | 0.08 |
 Ambulatory | 1000 (73) | 546 (75) | 454 (70) |  |
 Not ambulatory | 194 (14) | 124 (17) | 70 (11) |  |
 Unknown/missing | 178 (13) | 54 (7) | 124 (19) |  |
Intensive care variables | Â | Â | Â | Â |
Admission diagnosis category, n (%) | Â | Â | Â | 0.90 |
 Respiratory failure | 660 (48) | 346 (48) | 314 (48) |  |
 Gastrointestinal | 120 (9) | 67 (9) | 53 (8) |  |
 Sepsis, non-pulmonary | 164 (12) | 80 (11) | 84 (13) |  |
 Cardiovascular | 109 (8) | 60 (8) | 49 (8) |  |
 Other | 319 (23) | 171 (24) | 148 (23) |  |
Mechanically ventilated, n (%) | 873 (64) | 402 (56) | 471 (73) | 0.001 |
Delirious state, n (%)c | 550 (40) | 60 (8) | 490 (76) | <0.001 |
Received benzodiazepine bolus dose, n (%) | 176 (13) | 97 (13) | 79 (12) | 0.67 |
Received opioid bolus dose, n (%) | 276 (20) | 168 (23) | 108 (17) | 0.03 |
Received benzodiazepine and/or opioid infusion, n (%) | 227 (17) | 39 (5) | 188 (29) | <0.001 |